9Yaris N, Geviz N, Coskun T, et al. Serum carnitine levels during the doxorubicin therapy. Its role in cardiotoxicity[J]. J Exp Clin Cancer Res, 2002, 21(2):165-170.
10Dragojevis-Simic VM, Dobric SI, Bokonjic DR, et al. Amifostine protection against doxorubicin cardiotoxicity in rats[J]. Anticancer Drugs, 2004,15(2):169-178.
